Evans blue blocks P2X-purinoceptors in rat vas deferens

Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):684-7. doi: 10.1007/BF00167248.

Abstract

In rat vas deferens, Evans blue 100 microM increased contractions elicited by high K+ and by noradrenaline but markedly reduced contractions elicited by the P2X-purinoceptor-selective agonist alpha,beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was shifted to the right by Evans blue 30 microM and the maximal contraction was increased. In tissues incubated with nifedipine 10 microM, Evans blue 100 microM tended to increase the residual contraction elicited by noradrenaline and abolished the residual response to alpha, beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was progressively shifted to the right by increasing concentrations of Evans blue in the presence of nifedipine; maximal contractions were increased by Evans blue 10 and 30 but not 100 microM. From the shifts to the right caused by Evans blue 30 microM, apparent pKB values of 5.9 (no nifedipine) and 6.0 (nifedipine present) were calculated. It is concluded that Evans blue blocks P2X-purinoceptors in rat vas deferens and in addition causes a non-receptor-specific enhancement of contractions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Evans Blue / pharmacology*
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects*
  • Nifedipine / pharmacology
  • Norepinephrine / pharmacology
  • Potassium / pharmacology
  • Purinergic P2 Receptor Antagonists*
  • Rats
  • Rats, Wistar
  • Suramin / pharmacology
  • Vas Deferens / drug effects*

Substances

  • Purinergic P2 Receptor Antagonists
  • Evans Blue
  • Suramin
  • Adenosine Triphosphate
  • Nifedipine
  • alpha,beta-methyleneadenosine 5'-triphosphate
  • Potassium
  • Norepinephrine